Literature DB >> 25587009

Taurine Concentrations Decrease in Critically Ill Patients With Shock Given Enteral Nutrition.

Mechteld A R Vermeulen1, Mireille F M van Stijn2, Marlieke Visser3, Stéphanie M P Lemmens4, Alexander P J Houdijk5, Paul A M van Leeuwen4, Heleen M Oudemans-van Straaten6.   

Abstract

BACKGROUND: Nutrition studies in the intensive care unit (ICU) have shown that adequate enteral nutrition (EN) support has clinical benefits. However, the course of amino acid concentrations in plasma has never been investigated in patients admitted with shock receiving EN. We hypothesized that plasma concentrations, when deficit, increase during EN and that persistent deficiency is associated with poor outcome.
METHODS: In 33 septic or cardiogenic shock patients receiving EN, plasma amino acid concentrations were measured during 5 days. Changes in amino acid concentrations, correlations with clinical outcome variables, and regression analyses were studied.
RESULTS: On ICU admission, several plasma concentrations were deficient. Plasma concentrations of almost all amino acids increased. In contrast, taurine decreased by >50%, from 47.6 µmol/L on admission to 20.0 µmol/L at day 1, and remained low at day 5. Taurine (admission) correlated with time on mechanical ventilation (R = -0.42, P = .015). Taurine decrease within 24 hours correlated with Acute Physiology and Chronic Health Evaluation II predicted mortality (R = 0.43, P = .017) and Sequential Organ Failure Assessment score (R = 0.36, P = .05). Regression analyses confirmed correlations.
CONCLUSIONS: Several amino acids were deficient in plasma on ICU admission but increased during EN. Taurine concentrations declined and were associated with longer periods of mechanical ventilation and ICU support. Fast taurine decline correlated with severity of organ failure. These findings support the role of taurine during ischemia, reperfusion, and inflammation. Taurine may be an essential candidate to enrich nutrition support for critically ill patients, although more research is required.
© 2015 American Society for Parenteral and Enteral Nutrition.

Entities:  

Keywords:  ICU; amino acids; arginine; cardiogenic shock; glutamine; protein; sepsis

Mesh:

Substances:

Year:  2015        PMID: 25587009     DOI: 10.1177/0148607114567199

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  6 in total

1.  Amino Acid Loss during Continuous Venovenous Hemofiltration in Critically Ill Patients.

Authors:  Sandra N Stapel; Ruben J de Boer; Patrick J Thoral; Marc G Vervloet; Armand R J Girbes; Heleen M Oudemans-van Straaten
Journal:  Blood Purif       Date:  2019-07-10       Impact factor: 2.614

2.  Anti-Inflammatory Effect of Taurine in Burned Patients.

Authors:  Sima Lak; Alireza Ostadrahimi; Behrooz Nagili; Mohammad Asghari-Jafarabadi; Sanaz Beigzali; Feridoon Salehi; Roxana Djafarzadeh
Journal:  Adv Pharm Bull       Date:  2015-11-30

3.  Taurine administration ablates sepsis induced diaphragm weakness.

Authors:  Gerald S Supinski; Lin Wang; Elizabeth A Schroder; Leigh Ann P Callahan
Journal:  Respir Physiol Neurobiol       Date:  2019-09-07       Impact factor: 1.931

4.  Comprehensive metabolic amino acid flux analysis in critically ill patients.

Authors:  Nicolaas E P Deutz; Pierre Singer; Raven A Wierzchowska-McNew; Marina V Viana; Itai A Ben-David; Olivier Pantet; John J Thaden; Gabriella A M Ten Have; Mariëlle P K J Engelen; Mette M Berger
Journal:  Clin Nutr       Date:  2021-03-18       Impact factor: 7.324

5.  Clinical Nutrition of Critically Ill Patients in the Context of the Latest ESPEN Guidelines.

Authors:  Aleksandra Gostyńska; Maciej Stawny; Katarzyna Dettlaff; Anna Jelińska
Journal:  Medicina (Kaunas)       Date:  2019-12-02       Impact factor: 2.430

6.  The effects of Taurine supplementation on inflammatory markers and clinical outcomes in patients with traumatic brain injury: a double-blind randomized controlled trial.

Authors:  Mahsa Vahdat; Seyed Ahmad Hosseini; Farhad Soltani; Bahman Cheraghian; Masih Namjoonia
Journal:  Nutr J       Date:  2021-06-08       Impact factor: 3.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.